Home The Active Ingredient Matrix Ginkgo Biloba (Ginkgolide B)

Formulation Intelligence

Ginkgo Biloba (Ginkgolide B)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Ginkgo Biloba (Ginkgolide B).

Ginkgolide B is a potent, competitive antagonist of the platelet-activating factor (PAF) receptor, exerting significant neuroprotective and anti-inflammatory effects by modulating microvascular permeability and inhibiting PAF-induced platelet aggregation.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

6324617

Molecular Weight

424.4 g/mol

XLogP3 (Lipophilicity)

-0.4

IUPAC Name

(1R,3R,6R,7S,8S,10R,11R,12R,13S,16S,17R)-8-tert-butyl-6,12,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecane-5,15,18-trione

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

  • Bilobalide for [Synergistic neuroprotection and attenuation of glutamate-induced excitotoxicity]
  • Quercetin for [Enhanced antioxidant capacity and vascular endothelial protection]

Biological Formulation Enhancers

  • Phosphatidylcholine for [Improving lipophilicity and membrane permeability via phytosomal complexation]
  • Piperine for [Inhibition of P-glycoprotein mediated efflux to increase systemic exposure]

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Ginkgo Biloba (Ginkgolide B) across standard consumer modalities.

💊 Standard Capsules

The low aqueous solubility of Ginkgolide B requires the use of solid dispersion or micronization to ensure consistent dissolution and prevent poor bioavailability in standard dry powder fills.

🍬 Gummy & Pectin Formats

Maintaining the structural integrity of the terpene trilactone core is challenging due to the potential for hydrolytic degradation during the high-temperature, high-moisture gummy manufacturing process.

🔬 Thin-Film Oral Strips

The relatively high therapeutic dose required for Ginkgolide B exceeds the typical 20-30mg payload capacity of thin-film oral strips, necessitating complexation to maintain film elasticity.

For Brand Founders

Formulate with Ginkgo Biloba (Ginkgolide B)

Ready to launch a product featuring Ginkgo Biloba (Ginkgolide B)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Ginkgo Biloba (Ginkgolide B) Bioavailability

Need absolute proof that your Ginkgo Biloba (Ginkgolide B) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Ginkgo Biloba (Ginkgolide B) Degradation Testing

Is your Ginkgo Biloba (Ginkgolide B) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation